C4 Therapeutics, Inc. (NASDAQ:CCCC) IPO
IPO
Priced at US$19.00 a share on Oct 1, 2020.
- Price
- US$19.00 a share
- Shares offered
- 9,600,000 shares of common stock
- Offering size
- US$182.4 million
- Underwriters' option
- Up to 1,440,000 more shares
- Underwriters
- Jefferies, Evercore ISI, BMO Capital Markets, UBS Investment Bank · In the order on the cover
- Shares delivered
- On or about Oct 6, 2020
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Aug 6, 2020 |
| Filed publicly | Sep 10, 2020 |
| Amended once | Sep 28, 2020 |
| Shares registered with an exchange | Sep 28, 2020 |
| Declared effective by the SEC | Oct 1, 2020 |
| Final prospectus, with the price | Oct 2, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 2, 2020 |
| EFFECT · Notice that a registration is effective | Oct 1, 2020 |
| S-1MEF · Registration of more shares for the same offering | Oct 1, 2020 |
| CERT · Exchange's certificate of listing | Oct 1, 2020 |
| CORRESP · Letter to the SEC | Sep 29, 2020 |
| CORRESP · Letter to the SEC | Sep 29, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 28, 2020 |
| S-1/A · Registration statement, amended | Sep 28, 2020 |
| CORRESP · Letter to the SEC | Sep 15, 2020 |
| CORRESP · Letter to the SEC | Sep 10, 2020 |
| S-1 · Registration statement | Sep 10, 2020 |
| UPLOAD · Letter from the SEC | Sep 2, 2020 |
| DRS · Draft registration statement | Aug 6, 2020 |
From the cover of the final prospectus (424B4) filed Oct 2, 2020